Document Detail


Management of peripartum cardiomyopathy.
MedLine Citation:
PMID:  23007906     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
Peripartum cardiomyopathy is diagnosed in women who develop systolic heart failure in the last month of pregnancy or within 5 months of delivery. This diagnosis should not be made in women with pre-existing cardiac disease or another cause of cardiac dysfunction. To prevent delay in diagnosis and treatment, a high index of suspicion is required given the overlapping symptoms of late pregnancy and heart failure. Traditional heart failure medical therapies are indicated, although drugs must be carefully reviewed for safety during pregnancy and lactation. Long-term prognosis is largely determined by the degree of ventricular recovery. Patients with acute or persistent hemodynamic compromise despite medical therapy should be considered for mechanical circulatory support and evaluated promptly for cardiac transplantation. A multidisciplinary team is required to care for patients with peripartum cardiomyopathy through parturition and beyond. All peripartum cardiomyopathy patients should be counseled that repeat pregnancy can negatively impact cardiac function and lead to recurrent heart failure or even death. Patients with persistent ventricular dysfunction should be strongly advised against another pregnancy.
Authors:
Garrick C Stewart
Related Documents :
19538266 - Q fever during pregnancy: a cause of poor fetal and maternal outcome.
24290526 - Complexity-loss in fetal heart rate dynamics during labor as a potential biomarker of a...
8301676 - Ocular toxoplasmosis.
3952596 - The effect of tetracycline treatment on chlamydial salpingitis and subsequent fertility...
21329916 - Ambient air pollution and congenital heart disease; a register-based study.
12221516 - The influence of fetoabdominal tissues on fetal ecgs and mcgs.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current treatment options in cardiovascular medicine     Volume:  14     ISSN:  1534-3189     ISO Abbreviation:  Curr Treat Options Cardiovasc Med     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-27     Completed Date:  2012-11-28     Revised Date:  2013-07-25    
Medline Journal Info:
Nlm Unique ID:  9815942     Medline TA:  Curr Treat Options Cardiovasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  622-36     Citation Subset:  -    
Affiliation:
Division of Cardiovascular Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA, gcstewart@partners.org.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Anesthesia for children with mitochondrial disorders: a national survey and review.
Next Document:  Gene-expression analysis reveals that embryonic stem cells cultured under osteogenic conditions prod...